Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421410![]() (US10508086, Example 1 | US10995073, Example 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.41E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421411![]() (US10508086, Example 2 | US10995073, Example 2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421412![]() (US10508086, Example 3 | US10995073, Example 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.28E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421413![]() (US10508086, Example 4 | US10995073, Example 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.91E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421414![]() (US10508086, Example 5 | US10995073, Example 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.76E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421415![]() (US10508086, Example 6 | US10995073, Example 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.32E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421416![]() (US10508086, Example 7 | US10995073, Example 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.79E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421417![]() (US10508086, Example 8 | US10995073, Example 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.51E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421418![]() (US10508086, Example 9 | US10995073, Example 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.04E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421419![]() (US10508086, Example 10 | US10995073, Example 10) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.42E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421420![]() (US10508086, Example 11 | US10995073, Example 11) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.67E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421421![]() (US10508086, Example 12 | US10995073, Example 12) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.29E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421422![]() (US10508086, Example 13 | US10995073, Example 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.12E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421423![]() (N-(1-Methylcyclopropyl)-1-[2-(2-oxooxazolidin-3-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.28E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421424![]() (US10508086, Example 15 | US10995073, Example 15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.59E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421425![]() (US10508086, Example 16 | US10995073, Example 16) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.39E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421426![]() (US10508086, Example 17 | US10995073, Example 17) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.78E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421427![]() (US10508086, Example 18 | US10995073, Example 18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.56E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421428![]() (US10508086, Example 19 | US10995073, Example 19) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.36E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421429![]() (US10508086, Example 20 | US10995073, Example 20) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421430![]() (N-(1-Methylcyclopropyl)-1-[2-(2-oxoimidazolidin-1-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.23E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421431![]() (US10508086, Example 22 | US10995073, Example 22) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.18E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421432![]() (US10508086, Example 23 | US10995073, Example 23) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.83E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421433![]() (US10508086, Example 24 | US10995073, Example 24) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421434![]() (N-(1-Methylcyclopropyl)-1-[2-(3-methyl-2-oxo-imida...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.92E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421435![]() (US10508086, Example 26 | US10995073, Example 26) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.99E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421436![]() (US10508086, Example 27 | US10995073, Example 27) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 925 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421437![]() (US10508086, Example 28 | US10995073, Example 28) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 352 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421438![]() (US10508086, Example 29 | US10995073, Example 29) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.46E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421439![]() (US10508086, Example 30 | US10995073, Example 30) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.57E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421440![]() (US10508086, Example 31 | US10995073, Example 31) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.91E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421441![]() (US10508086, Example 32 | US10995073, Example 32) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.86E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421442![]() (US10508086, Example 33 | US10995073, Example 33) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.31E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421443![]() (US10508086, Example 34 | US10995073, Example 34) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.21E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421444![]() (US10508086, Example 35 | US10995073, Example 35) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.69E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421445![]() (US10508086, Example 36 | US10995073, Example 36) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.17E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421446![]() (US10508086, Example 37 | US10995073, Example 37) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.15E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421447![]() (US10508086, Example 38 | US10995073, Example 38) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.72E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421448![]() (US10508086, Example 39 | US10995073, Example 39) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.74E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421449![]() (US10508086, Example 40 | US10995073, Example 40) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421450![]() (US10508086, Example 41 | US10995073, Example 41) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.77E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421451![]() (US10508086, Example 42 | US10995073, Example 42) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.35E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421452![]() (US10508086, Example 43 | US10995073, Example 43) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.25E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421453![]() (US10508086, Example 44 | US10995073, Example 44) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.35E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421454![]() (US10508086, Example 45 | US10995073, Example 45) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.20E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421455![]() (US10508086, Example 46 | US10995073, Example 46) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.75E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421456![]() (US10508086, Example 47 | US10995073, Example 47) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.72E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421457![]() (US10508086, Example 48 | US10995073, Example 48) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.83E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421458![]() (US10508086, Example 49 | US10995073, Example 49) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.07E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421459![]() (US10508086, Example 50 | US10995073, Example 50) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.91E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 218 total ) | Next | Last >> |